BPC 157 American Wellness Pharmacy Multifunctionality and Possible Medical Application of the BPC 157 PeptideLiterature and Patent Review The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA to Convene Pharmacy Compounding Advisory Committee in July FDA to weigh easing limits on peptides promoted by RFK Jr. NBC 6 South Florida Everything You Need to Know About the FDA Peptide Ban